At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Simultaneous Administration of Norepinephrine, Angiotensin II, and Vasopressin in Septic Shock Patients
In Brief
A Phase 3 clinical trial evaluating Simultaneous administration of vasopressors and Successive administration of vasopressors for Shock, Septic. Completed, enrolled 79 participants across 2 sites in 2 countries.
Detailed Summary
The goal of this prospective randomized controlled trial is to compare the effects of classic stepwise vs. early balanced multimodal vasopressor strategies in septic shock.
Study Details
Timeline
Interventions
Early, simultaneous administration of norepinephrine, angiotensin II, and vasopressin.
Administration and titration of norepinephrine and vasopressin. Administration of additional vasoactive drugs (epinephrine, methylene blue, angiotensin II or dopamine) as per clinical team. Initiation of inotropes (dobutamin, levosimendan, milrinone) as per clinical team decision.